32765504|t|Effects of IL-34 on Macrophage Immunological Profile in Response to Alzheimer's-Related Abeta42 Assemblies.
32765504|a|Interleukin-34 (IL-34) is a recently discovered cytokine that acts as a second ligand of the colony stimulating factor 1 receptor (CSF1R) in addition to macrophage colony-stimulating factor (M-CSF). Similar to M-CSF, IL-34 also stimulates bone marrow (BM)-derived monocyte survival and differentiation into macrophages. Growing evidence suggests that peripheral BM-derived monocyte/macrophages (BMMO) play a key role in the physiological clearance of cerebral amyloid beta-protein (Abeta). Abeta42 forms are especially neurotoxic and highly associated with Alzheimer's disease (AD). As a ligand of CSF1R, IL-34 may be relevant to innate immune responses in AD. To investigate how IL-34 affects macrophage phenotype in response to structurally defined and stabilized Abeta42 oligomers and preformed fibrils, we characterized murine BMMO cultured in media containing M-CSF, IL-34, or regimens involving both cytokines. We found that the immunological profile and activation phenotype of IL-34-stimulated BMMO differed significantly from those cultured with M-CSF alone. Specifically, macrophage uptake of fibrillar or oligomeric Abeta42 was markedly reduced following exposure to IL-34 compared to M-CSF. Surface expression of type B scavenger receptor CD36, known to facilitate Abeta recognition and uptake, was modified following treatment with IL-34. Similarly, IL-34 macrophages expressed lower levels of proteins involved in both Abeta uptake (triggering receptor expressed on myeloid cells 2, TREM2) as well as Abeta-degradation (matrix metallopeptidase 9, MMP-9). Interestingly, intracellular compartmentalization of Abeta visualized by staining of early endosome antigen 1 (EEA1) was not affected by IL-34. Macrophage characteristics associated with an anti-inflammatory and pro-wound healing phenotype, including processes length and morphology, were also quantified, and macrophages stimulated with IL-34 alone displayed less process elongation in response to Abeta42 compared to those cultured with M-CSF. Further, monocytes treated with IL-34 alone yielded fewer mature macrophages than those treated with M-CSF alone or in combination with IL-34. Our data indicate that IL-34 impairs monocyte differentiation into macrophages and reduces their ability to uptake pathological forms of Abeta. Given the critical role of macrophage-mediated Abeta clearance in both murine models and patients with AD, future work should investigate the therapeutic potential of modulating IL-34 in vivo to increase macrophage-mediated Abeta clearance and prevent disease development.
32765504	11	16	IL-34	Gene	76527
32765504	68	79	Alzheimer's	Disease	MESH:D000544
32765504	108	122	Interleukin-34	Gene	76527
32765504	124	129	IL-34	Gene	76527
32765504	239	244	CSF1R	Gene	12978
32765504	261	297	macrophage colony-stimulating factor	Gene	12977
32765504	299	304	M-CSF	Gene	12977
32765504	318	323	M-CSF	Gene	12977
32765504	325	330	IL-34	Gene	76527
32765504	559	588	cerebral amyloid beta-protein	Disease	MESH:D016657
32765504	590	595	Abeta	Disease	MESH:C000718787
32765504	627	637	neurotoxic	Disease	MESH:D020258
32765504	665	684	Alzheimer's disease	Disease	MESH:D000544
32765504	686	688	AD	Disease	MESH:D000544
32765504	706	711	CSF1R	Gene	12978
32765504	713	718	IL-34	Gene	76527
32765504	765	767	AD	Disease	MESH:D000544
32765504	788	793	IL-34	Gene	76527
32765504	932	938	murine	Species	10090
32765504	973	978	M-CSF	Gene	12977
32765504	980	985	IL-34	Gene	76527
32765504	1093	1098	IL-34	Gene	76527
32765504	1163	1168	M-CSF	Gene	12977
32765504	1286	1291	IL-34	Gene	76527
32765504	1304	1309	M-CSF	Gene	12977
32765504	1385	1390	Abeta	Disease	MESH:C000718787
32765504	1453	1458	IL-34	Gene	76527
32765504	1471	1476	IL-34	Gene	76527
32765504	1541	1546	Abeta	Disease	MESH:C000718787
32765504	1555	1603	triggering receptor expressed on myeloid cells 2	Gene	83433
32765504	1605	1610	TREM2	Gene	83433
32765504	1623	1628	Abeta	Disease	MESH:C000718787
32765504	1642	1667	matrix metallopeptidase 9	Gene	17395
32765504	1669	1674	MMP-9	Gene	17395
32765504	1730	1735	Abeta	Disease	MESH:C000718787
32765504	1762	1786	early endosome antigen 1	Gene	216238
32765504	1788	1792	EEA1	Gene	216238
32765504	1814	1819	IL-34	Gene	76527
32765504	1872	1884	inflammatory	Disease	MESH:D007249
32765504	2015	2020	IL-34	Gene	76527
32765504	2116	2121	M-CSF	Gene	12977
32765504	2155	2160	IL-34	Gene	76527
32765504	2224	2229	M-CSF	Gene	12977
32765504	2259	2264	IL-34	Gene	76527
32765504	2289	2294	IL-34	Gene	76527
32765504	2403	2408	Abeta	Disease	MESH:C000718787
32765504	2457	2462	Abeta	Disease	MESH:C000718787
32765504	2481	2487	murine	Species	10090
32765504	2499	2507	patients	Species	9606
32765504	2513	2515	AD	Disease	MESH:D000544
32765504	2588	2593	IL-34	Gene	76527
32765504	2634	2639	Abeta	Disease	MESH:C000718787
32765504	Negative_Correlation	17395	76527
32765504	Association	12978	76527
32765504	Association	MESH:C000718787	216238
32765504	Association	MESH:D000544	76527
32765504	Negative_Correlation	MESH:C000718787	76527
32765504	Association	MESH:C000718787	83433
32765504	Association	12977	76527
32765504	Negative_Correlation	76527	83433
32765504	Association	MESH:C000718787	17395

